Protective effect of hormone therapy among women with hysterectomy/oophorectomy

Chen, L., Mishra, G. D., Dobson, A. J., Wilson, L. F. and Jones, M. A. (2017) Protective effect of hormone therapy among women with hysterectomy/oophorectomy. Human Reproduction, 32 4: 885-892. doi:10.1093/humrep/dex017


Author Chen, L.
Mishra, G. D.
Dobson, A. J.
Wilson, L. F.
Jones, M. A.
Title Protective effect of hormone therapy among women with hysterectomy/oophorectomy
Journal name Human Reproduction   Check publisher's open access policy
ISSN 1460-2350
0268-1161
Publication date 2017-04-01
Year available 2017
Sub-type Article (original research)
DOI 10.1093/humrep/dex017
Open Access Status Not yet assessed
Volume 32
Issue 4
Start page 885
End page 892
Total pages 8
Place of publication Oxford, United Kingdom
Publisher Oxford University Press
Language eng
Subject 2743 Reproductive Medicine
2742 Rehabilitation
2729 Obstetrics and Gynaecology
Abstract STUDY QUESTION Does exposure to menopausal hormone therapy (MHT) in mid-aged women alter their risk of cardiovascular disease (CVD) mortality and all-cause mortality SUMMARY ANSWER MHT soon after menopause is unlikely to increase the risk of CVD mortality or all-cause mortality and may have a protective effect for women with hysterectomy/oophorectomy. WHAT IS KNOWN ALREADY The balance of benefits and risks of MHT are currently unclear and may differ according to when treatment starts and whether women have an intact uterus. STUDY DESIGN, SIZE, DURATION A total of 13 715 participants from the mid-aged population-based cohort (born 1946-1951) of the Australian Longitudinal Study on Women's Health (ALSWH) were followed from 1998 to 2013. PARTICIPANTS/MATERIALS, SETTING, METHODS The measures included cardiovascular and all-cause mortality, exposure to MHT and menopausal status (based on 3-yearly self-reports). Electronic prescriptions data on MHT were also available from mid-2002 onwards. At each follow-up survey wave, participants were classified as: An existing user of MHT, an initiator of MHT or a non-initiator of MHT. MAIN RESULTS AND THE ROLE OF CHANCE After adjusting for confounding variables, existing users of MHT had a reduced risk (hazard ratio 0.63; 95% CI, 0.43-0.92) of CVD mortality compared with non-initiators. Insufficient evidence of an association was identified for initiators of MHT (0.66; 0.35-1.24). For all-cause mortality, risks were reduced for both initiators (0.69; 0.55-0.87) and existing users (0.80; 0.70-0.91). In a subgroup analysis, women with hysterectomy/oophorectomy had lower risks of CVD mortality for both initiators (0.14; 0.02-0.98) and existing users (0.55; 0.34-0.90), but no evidence of an association was found for women whose MHT commenced during or after menopause. Similarly for all-cause mortality, only the women with hysterectomy/oophorectomy had lower risks for both initiators (0.47; 0.31-0.70) and existing users (0.69; 0.58-0.82). LIMITATIONS, REASONS FOR CAUTION Limitations include the observational nature of the study, the small number of deaths, MHT use being self-reported and the classification of menopausal status also being based on self-reported information. WIDER IMPLICATIONS OF THE FINDINGS Women considering MHT soon after menopause can be reassured that the treatment is unlikely to increase their risk of CVD mortality or all-cause mortality.
Formatted abstract
Study question: Does exposure to menopausal hormone therapy (MHT) in mid-aged women alter their risk of cardiovascular disease (CVD) mortality and all-cause mortality

Summary answer: MHT soon after menopause is unlikely to increase the risk of CVD mortality or all-cause mortality and may have a protective effect for women with hysterectomy/oophorectomy.

What is known already: The balance of benefits and risks of MHT are currently unclear and may differ according to when treatment starts and whether women have an intact uterus.

Study design, size, duration: A total of 13 715 participants from the mid-aged population-based cohort (born 1946-1951) of the Australian Longitudinal Study on Women's Health (ALSWH) were followed from 1998 to 2013.

Participants/materials, setting, methods: The measures included cardiovascular and all-cause mortality, exposure to MHT and menopausal status (based on 3-yearly self-reports). Electronic prescriptions data on MHT were also available from mid-2002 onwards. At each follow-up survey wave, participants were classified as: An existing user of MHT, an initiator of MHT or a non-initiator of MHT.

Main results and the role of chance: After adjusting for confounding variables, existing users of MHT had a reduced risk (hazard ratio 0.63; 95% CI, 0.43-0.92) of CVD mortality compared with non-initiators. Insufficient evidence of an association was identified for initiators of MHT (0.66; 0.35-1.24). For all-cause mortality, risks were reduced for both initiators (0.69; 0.55-0.87) and existing users (0.80; 0.70-0.91). In a subgroup analysis, women with hysterectomy/oophorectomy had lower risks of CVD mortality for both initiators (0.14; 0.02-0.98) and existing users (0.55; 0.34-0.90), but no evidence of an association was found for women whose MHT commenced during or after menopause. Similarly for all-cause mortality, only the women with hysterectomy/oophorectomy had lower risks for both initiators (0.47; 0.31-0.70) and existing users (0.69; 0.58-0.82).

Limitations, reasons for caution: Limitations include the observational nature of the study, the small number of deaths, MHT use being self-reported and the classification of menopausal status also being based on self-reported information.

Wider implications of the findings: Women considering MHT soon after menopause can be reassured that the treatment is unlikely to increase their risk of CVD mortality or all-cause mortality.
Keyword Cardiovascular mortality
Longitudinal study
Menopausal hormone therapy
Mortality
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
School of Public Health Publications
Admin Only - School of Public Health
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Tue, 25 Apr 2017, 00:26:36 EST by Web Cron on behalf of Learning and Research Services (UQ Library)